Giessen Stroke Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Giessen

About this trial

The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age above 18

Patient admitted for acute stroke (Stroke Unit or Intensive Care Unit)

Informed Consent

Disqualifiers

Inclusion criteria not met

Trial population

All patients admitted for acute stroke

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Modified Rankin-scale after 3 months

Funtional Outcome measured by modified Rankin-scale. The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.

Time frame
3 months after initial stroke
2

Modified Rankin-scale after 12 months

Funtional Outcome measured by modified Rankin-scale. The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.

Time frame
12 months after initial stroke

Secondary outcomes

1

Intrahospital Mortality

Number of patients that died during initial hospital phase.

Time frame
Up to 6 weeks after initial stroke.
2

Short-term and long-term mortality

Number of patients that died over the course of 3 and 12 months

Time frame
3 months and 12 after initial stroke
3

New stroke

Number of patients with new stroke.

Time frame
3 and 12 months after initial Stroke

Other outcomes

1

Recurring pneumonia during follow-up

Number of patients with recurring pneumonia.

Time frame
3 and 12 months after initial Stroke
2

Epilepsy

Number of patients with occurence of epilepsy and its treatment

Time frame
3 and 12 months after initial Stroke
3

Cognitive decline

Number of patients with cognitive decline as measured with the Montreal Cognitive Assessment

Time frame
3 and 12 months after initial Stroke
4

Tracheostomy

Number of patients with need for longterm tracheostomy

Time frame
3 and 12 months after initial Stroke

Sponsors and contacts

Click on the lead sponsor to view all of their trials.